Lupus anticoagulant-hypoprothrombinemia syndrome and immunoglobulin-A vasculitis: a report of Japanese sibling cases and review of the literature

Rheumatology International
Kaori FujiwaraAkira Shimada

Abstract

Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare bleeding disorder caused by antiprothrombin antibodies. LAHPS is associated with systemic lupus erythematosus (SLE) or infections. We describe two Japanese brothers with immunoglobulin-A vasculitis (IgAV) who met the diagnostic criteria of LAHPS. They presented with palpable purpura and abdominal pain, and had a prolonged activated partial thromboplastin time (APTT) and prothrombin deficiency with the presence of lupus anticoagulant. Pediatric LAHPS was reviewed in abstracts from the Japan Medical Abstracts Society that were written in Japanese and PubMed or Web of Science-listed articles in English between 1996 and 2019. Including our cases, pediatric LAHPS has been reported in 40 Japanese and 46 non-Japanese patients. We summarized the clinical and laboratory characteristics of all 86 cases, and found only one Japanese LAHPS case with IgAV, except for our cases. Of the 86 cases, most were associated with infections followed by SLE. The presence of SLE, older age, lower prothrombin levels, severe bleeding symptoms, and positivity of immunoglobulin G anticardiolipin antibodies and anticardiolipin/β2-glycoprotein I antibodies and/or β2-glycoprotein I-dependent an...Continue Reading

References

Feb 5, 1999·The Journal of Pediatrics·C MaleI Pabinger
Sep 5, 2003·Emergency Medicine Journal : EMJ·A K AndersonR Liesner
Apr 21, 2007·Journal of Paediatrics and Child Health·Amanda L DaveyAnn Cuthbert
Jan 13, 2010·International Journal of Dermatology·Lenis M GonzálezRobert A Schwartz
Jan 25, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Qiang LinXiaozhong Li
Apr 25, 2012·European Journal of Pediatrics·Karin KnobeAndreas Hillarp
Jan 10, 2013·BMJ Case Reports·Cristiana CarvalhoTeresa Rezende
Jan 29, 2013·Acta Paediatrica·Giuseppe IndolfiMassimo Resti
Mar 7, 2014·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Takeshi ShimizuKazuo Itabashi
Apr 16, 2014·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Joseph J MoellmanRichard Sinert
May 29, 2014·Korean journal of pediatrics·Ji Soo KimDae Chul Jeong
May 2, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·T SarkerM Rajpurkar
May 16, 2015·International Journal of Laboratory Hematology·K A Moser, J Puetz
Jul 31, 2016·American Journal of Clinical Pathology·Jing Jin, James L Zehnder
Nov 20, 2016·Pediatric Blood & Cancer·Aimee FoordArash Mahajerin
Dec 24, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Sreejesh SreedharanunniPankaj Malhotra
Aug 9, 2017·Journal of Pediatric Hematology/oncology·Patcharee KomvilaisakSurapon Wiangnon
Nov 16, 2017·Indian Journal of Pediatrics·Rohit BhowmickSathish Kumar T
Apr 18, 2018·International Journal of Dermatology·Hsien-Yi ChiuFung-Chang Sung

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.